T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Humana
HUM
|
+$2.39B |
| 2 |
UnitedHealth
UNH
|
+$1.47B |
| 3 |
GE Aerospace
GE
|
+$1.33B |
| 4 |
Amazon
AMZN
|
+$1.18B |
| 5 |
AbbVie
ABBV
|
+$1.13B |
Top Sells
| 1 |
Boeing
BA
|
+$1.56B |
| 2 |
Nike
NKE
|
+$1.42B |
| 3 |
Becton Dickinson
BDX
|
+$1.33B |
| 4 |
Alibaba
BABA
|
+$1.23B |
| 5 |
JPMorgan Chase
JPM
|
+$1.22B |
Sector Composition
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.27% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
651
Fortinet
FTNT
$60.9B
| $77.1M | 0.01% |
3,808,385
+97,685
| +3% | +$1.98M |
|
|
TCDA
652
DELISTED
Tricida, Inc. Common Stock
TCDA
| $76.8M | 0.01% |
3,490,263
-938,955
| -21% | -$20.7M |
|
653
Charles River Laboratories
CRL
$7.54B
| $76.4M | 0.01% |
605,077
+15,868
| +3% | +$2M |
|
654
Parker-Hannifin
PH
$96.9B
| $76.2M | 0.01% |
587,401
+347,719
| +145% | +$45.1M |
|
655
Coca-Cola Consolidated
COKE
$10.5B
| $75.6M | 0.01% |
3,624,600
+554,890
| +18% | +$11.6M |
|
656
Welltower
WELL
$112B
| $75.4M | 0.01% |
1,645,958
+892,096
| +118% | +$40.8M |
|
|
FTCH
657
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $74.9M | 0.01% |
9,482,946
-872,306
| -8% | -$6.89M |
|
|
AIMT
658
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $74.9M | 0.01% |
5,192,673
-429,865
| -8% | -$6.2M |
|
659
NVR
NVR
$23B
| $74.9M | 0.01% |
29,142
-48,333
| -62% | -$124M |
|
660
Helen of Troy
HELE
$550M
| $74.2M | 0.01% |
515,511
+4,051
| +0.8% | +$583K |
|
661
Liberty Latin America Class C
LILAK
$1.54B
| $74.2M | 0.01% |
7,683,872
-1,126,741
| -13% | -$10.9M |
|
662
Waste Management
WM
$87.7B
| $73.7M | 0.01% |
796,454
+62,496
| +9% | +$5.78M |
|
663
Exelon
EXC
$43.8B
| $73.3M | 0.01% |
2,791,204
+217,934
| +8% | +$5.72M |
|
|
PPD
664
DELISTED
PPD, Inc. Common Stock
PPD
| $73.2M | 0.01% |
+4,108,683
| New | +$73.2M |
|
665
Heritage Financial
HFWA
$842M
| $72.9M | 0.01% |
3,643,611
+68,213
| +2% | +$1.36M |
|
666
Generac Holdings
GNRC
$10.9B
| $72.4M | 0.01% |
776,970
+53,987
| +7% | +$5.03M |
|
667
Jazz Pharmaceuticals
JAZZ
$7.7B
| $72.4M | 0.01% |
725,531
+504,217
| +228% | +$50.3M |
|
668
CACI
CACI
$10.7B
| $72.1M | 0.01% |
341,520
+90,477
| +36% | +$19.1M |
|
669
UFP Industries
UFPI
$5.84B
| $72.1M | 0.01% |
1,937,626
+62,576
| +3% | +$2.33M |
|
670
Parsons
PSN
$7.98B
| $71.7M | 0.01% |
2,242,797
+50,889
| +2% | +$1.63M |
|
671
Vornado Realty Trust
VNO
$7.77B
| $71.6M | 0.01% |
1,977,906
-199,900
| -9% | -$7.24M |
|
|
RDUS
672
DELISTED
Radius Health, Inc.
RDUS
| $71.6M | 0.01% |
5,505,633
-334,661
| -6% | -$4.35M |
|
673
Primerica
PRI
$8.74B
| $71.6M | 0.01% |
808,799
+44,885
| +6% | +$3.97M |
|
674
LivaNova
LIVN
$3.09B
| $71.4M | 0.01% |
1,577,659
-1,188,862
| -43% | -$53.8M |
|
|
MTOR
675
DELISTED
MERITOR, Inc.
MTOR
| $71.4M | 0.01% |
5,385,479
+1,993,937
| +59% | +$26.4M |
|